Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Clin Microbiol Infect Dis ; 33(9): 1497-503, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24718613

RESUMO

Trichosporon asahii has been recognized as an emerging opportunistic agent for invasive infections, mainly in immunocompromised patients. Urinary tract infections by this pathogen may also occur, especially in patients with urinary obstruction or those undergoing vesical catheterization and antibiotic treatment. Many outbreaks of Trichosporon spp. have been detected after urinary catheter manipulations. We report the molecular-epidemiological characterization of T. asahii in our institution using the DiversiLab system for the molecular strain typing and compare three different methods for susceptibility testing. Our results present T. asahii as an emergent pathogen in elderly patients with urinary drainage devices that can be adequately treated with triazoles, with voriconazole being the most active. Broth dilution and Vitek 2 had good concordance, while Etest showed more discrepancies. In addition, the DiversiLab system for clonal strain typing may be a useful tool for fast and accurate management of nosocomial outbreaks.


Assuntos
Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Trichosporon/classificação , Trichosporon/isolamento & purificação , Tricosporonose/epidemiologia , Tricosporonose/microbiologia , Idoso , Idoso de 80 Anos ou mais , Infecções Relacionadas a Cateter/tratamento farmacológico , Infecções Relacionadas a Cateter/epidemiologia , Infecções Relacionadas a Cateter/microbiologia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Epidemiologia Molecular , Tipagem Molecular/métodos , Técnicas de Tipagem Micológica/métodos , Triazóis/farmacologia , Triazóis/uso terapêutico , Trichosporon/efeitos dos fármacos , Trichosporon/genética , Tricosporonose/tratamento farmacológico , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/epidemiologia , Infecções Urinárias/microbiologia
2.
Rev Esp Med Nucl ; 27(1): 13-21, 2008.
Artigo em Espanhol | MEDLINE | ID: mdl-18208777

RESUMO

UNLABELLED: Dihydrotetrabenazine (2-hydroxy-3-isobutyl-9,10-dimethoxy-1,3,4,6,7-hexahydro-11bH-benzo[a]-quinolizine, DTBZ) has become the ideal radioligand for the presynaptic vesicular monoamine transporter VMAT2 based on its high binding affinity and optimal lipophilicity. OBJECTIVE: To develop an automatic procedure for labelling DTBZ with carbon-11, which has been shown to be a highly effective marker for in vivo studies of neuronal losses in animal models with Parkinson's disease using positron emission tomography (PET). MATERIALS AND METHODS: We have developed a new fully automated synthesis procedure to obtain 11C-(+)DTBZ quickly and simply through labelling the precursor -(+)desmethyldihy-drotetrabenazine- at room temperature in the presence of dimethyl sulfoxide (DMSO) and potassium hydroxide (KOH), using 11CH3I as primary precursor. The final purification was carried out by solid phase extraction using commercially available cartridges and the residual solvents (DMSO and ethyl ether) were eliminated by evaporation. RESULTS: The whole procedure was automated, and after 54 syntheses, an average production of 1.94 GBq of sterile, pyrogen-free 11C-(+)DTBZ with a radiochemical purity > 99 % was obtained with 5 minutes irradiation and 6 minutes of synthesis after 11CH3I production. 11C-(+)DTBZ binding to presynaptic dopamine nerve terminals has been demonstrated by MicroPET studies in Wistar rats and M. Fascicularis monkeys. CONCLUSIONS: This new synthesis procedure is quick and simple, due to optimised techniques, which have allowed elimination of residual solvents based on their polarity for the final purification. It is also applicable to other automatic syntheses for obtaining compounds labelled by methylation reactions.


Assuntos
Radioisótopos de Carbono , Tomografia por Emissão de Pósitrons/métodos , Terminações Pré-Sinápticas/diagnóstico por imagem , Ensaio Radioligante , Compostos Radiofarmacêuticos/síntese química , Tetrabenazina/análogos & derivados , Proteínas Vesiculares de Transporte de Monoamina/análise , Automação , Cromatografia Líquida de Alta Pressão , Dimetil Sulfóxido , Dopamina , Contaminação de Medicamentos , Endotoxinas/análise , Éter , Humanos , Marcação por Isótopo/métodos , Terminações Pré-Sinápticas/química , Terminações Pré-Sinápticas/ultraestrutura , Controle de Qualidade , Receptores Pré-Sinápticos/química , Solventes , Tetrabenazina/síntese química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA